Focused on delivering commercial value, Linda advises companies and non-profit organizations of different sizes on intellectual property matters for innovations in a variety of life sciences fields.

Leveraging more than a decade of multifaceted scientific research experience, Linda designs and implements global patent estates and prepares competitive landscape, non-infringement, invalidity, and freedom-to-operate analyses. She also assists investors in the due diligence of patent assets in the context of financings, IPOs, and mergers and acquisitions. She is experienced in preparing and negotiating technology licensing confidentiality, collaborative research, and material transfer agreements.

Linda holds a Ph.D. degree in physical chemistry and a M.Sc. degree in biotechnology. During her interdisciplinary doctoral and postdoctoral training, she directly contributed to multiple drug and research tool inventions while also gaining extensive experience in a variety of life science fields, including biotechnology, molecular biology, immunology, oncology, genetics as well as research and diagnostic tools.

Linda enjoys working with inventors to turn scientific innovations into valuable patent assets. Clients turn to Linda to help secure intellectual property rights for a wide range of life science inventions, including antibody and protein therapies, nucleic acid therapeutics, cell therapies, immune-oncology therapeutics, vaccines, organ replacements, research tools and diagnostics.

Linda’s practice is supported by Fox Rothschild attorneys who are skilled with public offerings, corporate law and regulatory needs.